Cargando…
Respiratory effects of dexmedetomidine in the surgical patient requiring intensive care
INTRODUCTION: The α(2)-agonist dexmedetomidine is a new class of sedative drug that is being investigated for use in ICU settings. It is an effective agent for the management of sedation and analgesia after cardiac, general, orthopaedic, head and neck, oncological and vascular surgery in the ICU [1]...
Autores principales: | Venn, Richard M, Hell, John, Michael Grounds, R |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2000
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC29047/ https://www.ncbi.nlm.nih.gov/pubmed/11056756 |
Ejemplares similares
-
Respiratory effects of dexmedetomidine in the ICU
por: Hell, J, et al.
Publicado: (2000) -
Pharmacokinetics of dexmedetomidine infusions for patients in the intensive care unit
por: Venn, RM, et al.
Publicado: (2001) -
A comparison between dexmedetomidine and propofol for sedation in the intensive care unit
por: Venn, RM, et al.
Publicado: (2001) -
Dexmedetomidine for sedation in the medical ICU
por: Venn, RM, et al.
Publicado: (2000) -
Analgesic sparing effects of Dexmedetomidine in surgical intensive care patients
por: Sheikh, Nissar, et al.
Publicado: (2019)